Dying and surviving neurons have distinctive gene expression signatures in rat hippocampus. by Daniel R. Rojo (104661)

<i>In vivo</i> blocking of ICG-Glu-Glu-AE105 by uPA, the natural ligand. by Karina Juhl (2144860)

“…In all timepoints the two groups were significantly different with the group receiving only ICG-Glu-Glu-E105 having a 2 fold higher signal.</p>…”

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry by Sylvia Haas (414005)

“…The proportion of patients with TTR≥65% varied from 16.7% in Asia to 49.4% in Europe. There was a 2.6-fold increase in the risk of stroke/SE, 1.5-fold increase in the risk of major bleeding, and 2.4-fold increase in the risk of all-cause mortality with TTR<65% versus ≥65% after adjusting for potential confounders. …”

File S1 - A Genetically Encoded Reporter for Real-Time Imaging of Cofilin-Actin Rods in Living Neurons by Jianjie Mi (504427)

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry by Sylvia Haas (414005)

“…The proportion of patients with TTR≥65% varied from 16.7% in Asia to 49.4% in Europe. There was a 2.6-fold increase in the risk of stroke/SE, 1.5-fold increase in the risk of major bleeding, and 2.4-fold increase in the risk of all-cause mortality with TTR<65% versus ≥65% after adjusting for potential confounders. …”

Model of cdr2 action in mitosis. by Kevin J. O'Donovan (250670)

“…<p>Cdr2 levels increase in G2, peak in mitosis and decrease as cells exit mitosis. Nuclear envelope breakdown in prometaphase allows newly synthesized cdr2 access to c-myc protein, which, like other transcription factors <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010045#pone.0010045-Delcuve1" target="_blank">[61]</a>, partitions itself off DNA during chromatin condensation, coinciding with mitotic shutdown of transcription. …”

Model architecture and dynamics. by Kai Ueltzhöffer (754206)

“…Trajectories (red) started at an arbitrary point explore the phase space, due to the noise, but tend to stay close to one of the attractors, due to the deterministic dynamics. …”

Shape rescue in the midface phenotype in the Dp(16)1Yey/ <i>Ripply3</i>^<i>tm1b</i> compound mutant. by José Tomás Ahumada Saavedra (22290934)

“…On the left, the histogram of every point distance evaluated (in this case, more than 1.238.684 points) and the surface differences with the color code for the increase-decrease dimensions (Red to green).…”

<i>FoxD(RNAi)</i> animals display abnormal anterior pole, head patterning and midline gene expression. by M. Lucila Scimone (508003)

“…<p>(<b>A</b>) Upper panels: animals injected with <i>FoxD</i> dsRNA regenerated normally sized anterior blastemas with one eye (73/130) or smaller blastemas with no eyes (24/130) seven days following amputation. …”

Effect of probenecid on biopterin levels in the blood and urine after 6RBH₄ administration. by Akiko Ohashi (3202062)

“…“BH₄ + Pbc” (Student’s <i>t</i>-test), <i>P</i> = 0.03 at 30 min; <i>P</i> = 0.006 at 120 min; <i>P</i> = 0.02 at 180 min. 3) “BH₄ alone”, decreased (Paired <i>t</i>-test), 0-time <i>vs</i>. each data point from 60–300 min, <i>P</i><0.05. 4) “BH₄ + Pbc”, decreased (Paired <i>t</i>-test), 0-time <i>vs</i>. each data point from 30–300 min, <i>P</i><0.003. 5) “BH₄ alone” <i>vs</i>. …”

Differences in spinal excitability across the three pre-movement phases. by Michael J. Asmussen (399456)

“…<p>Group-averaged spinal excitability data (with standard error of the mean) for each pre-movement time point (i.e., PW1, PW2, PG) and muscle (FDI, ADM). …”

DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx by Tuo Pan (9264234)

“…Secondly, a propensity-score matched cohort (sivelestat vs control: 50 vs 50) was performed in these 665 patients. …”

Image1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

Image4_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

Image2_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

DataSheet1_Long term high glucose exposure induces premature senescence in retinal endothelial cells.pdf by Pietro Maria Bertelli (13431426)

Image5_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy.JPE... by Changzhen Ren (10649432)

“…We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

DataSheet1_Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy... by Changzhen Ren (10649432)

“…We aimed to determine whether empagliflozin (EMPA), an SGLT2 inhibitor, has a protective role against sunitinib (SNT)-induced cardiac dysfunction in a mouse model.…”

DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx by Tuo Pan (9264234)

“…Secondly, a propensity-score matched cohort (sivelestat vs control: 50 vs 50) was performed in these 665 patients. …”

Flowchart of study population. by Yan Zeng (120271)